Sorrento Therapeutics, Inc. short interest in 2020
In 2020, Sorrento Therapeutics, Inc.'s disclosed short interest ran from 16.47% of shares outstanding on 15 Jan 2020 to 27.99% on 31 Dec 2020, a change of +11.52 percentage points. The year's high was 31.29% on 30 Sep 2020 and its low 11.25% on 15 May 2020, averaging 21.31% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.55 days on 31 Jan 2020. Full history: Sorrento Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2020 in figures
- Start of year
- 16.47% (15 Jan 2020)
- End of year
- 27.99% (31 Dec 2020)
- Change
- +11.52 pp
- High
- 31.29% (30 Sep 2020)
- Low
- 11.25% (15 May 2020)
- Average
- 21.31%
- Highest days to cover
- 7.55 (31 Jan 2020)
- SEC filings marked
- 4
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 16.47% | 3.06 | |
| 31 Jan 2020 | 17.84% | 7.55 | |
| 14 Feb 2020 | 13.56% | 5.45 | |
| 28 Feb 2020 | 13.13% | 4.61 | |
| 13 Mar 2020 | 13.60% | 3.23 | 10-K filed |
| 31 Mar 2020 | 13.14% | 3.48 | |
| 15 Apr 2020 | 13.65% | 2.78 | |
| 30 Apr 2020 | 11.54% | 5.54 | |
| 15 May 2020 | 11.25% | 4.56 | 10-Q filed |
| 29 May 2020 | 17.67% | 1.00 | |
| 15 Jun 2020 | 19.68% | 1.54 | |
| 30 Jun 2020 | 23.88% | 2.24 | |
| 15 Jul 2020 | 23.08% | 2.15 | |
| 31 Jul 2020 | 21.61% | 2.47 | |
| 14 Aug 2020 | 22.34% | 1.00 | 10-Q filed |
| 31 Aug 2020 | 30.31% | 1.91 | |
| 15 Sep 2020 | 31.03% | 3.69 | |
| 30 Sep 2020 | 31.29% | 1.92 | |
| 15 Oct 2020 | 29.70% | 4.15 | |
| 30 Oct 2020 | 27.67% | 6.46 | |
| 13 Nov 2020 | 28.67% | 5.28 | 10-Q filed |
| 30 Nov 2020 | 26.21% | 4.46 | |
| 15 Dec 2020 | 26.23% | 6.83 | |
| 31 Dec 2020 | 27.99% | 4.88 |
See also: Sorrento Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.